LBLTF (Lattice Biologics) E10: $0.00 (As of Jun. 2021)


What is Lattice Biologics E10?

Lattice Biologics LBLTF -99.00% E10 is $0.00 as of Jun. 2021.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Lattice Biologics's adjusted earnings per share data for the three months ended in Jun. 2021 was $0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.00 for the trailing ten years ended in Jun. 2021.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-26), Lattice Biologics's current stock price is $0.0001. Lattice Biologics's E10 for the quarter that ended in Jun. 2021 was $0.00. Lattice Biologics's Shiller PE Ratio of today is .


Lattice Biologics  (OTCPK:LBLTF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Lattice Biologics E10 Related Terms


Lattice Biologics E10 Historical Data

* Premium members only.

The historical data trend for Lattice Biologics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lattice Biologics E10 Chart

Lattice Biologics Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Sep16 Sep17 Sep18 Sep19 Sep20
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.03 -2.58 0.00 -1.41 0.00

Lattice Biologics Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.69 0.00 -1.35 -1.75 0.00

LBLTF vs ABT, MDT, SYK: E10 Comparison

For the Medical Devices subindustry, Lattice Biologics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lattice Biologics Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lattice Biologics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lattice Biologics's Shiller PE Ratio falls into.



Lattice Biologics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lattice Biologics's adjusted earnings per share data for the three months ended in Jun. 2021 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2021 (Change)*Current CPI (Jun. 2021)
=-0/271.6960*271.6960
=0.000

Current CPI (Jun. 2021) = 271.6960.

Lattice Biologics Quarterly Data

per share eps CPI Adj_EPS
201109 6.360 226.889 7.616
201112 -19.876 225.672 -23.930
201203 0.000 229.392 0.000
201206 -0.046 229.478 -0.054
201209 -0.035 231.407 -0.041
201212 -0.181 229.601 -0.214
201303 0.000 232.773 0.000
201306 -0.020 233.504 -0.023
201309 -0.023 234.149 -0.027
201312 -0.164 233.049 -0.191
201403 -0.204 236.293 -0.235
201406 -0.016 238.343 -0.018
201409 -0.016 238.031 -0.018
201412 -0.218 234.812 -0.252
201503 -0.018 236.119 -0.021
201506 -0.007 238.638 -0.008
201509 -0.049 237.945 -0.056
201512 -0.330 236.525 -0.379
201603 -0.020 238.132 -0.023
201606 -0.040 241.018 -0.045
201609 -0.020 241.428 -0.023
201612 -0.020 241.432 -0.023
201703 -0.010 243.801 -0.011
201706 0.020 244.955 0.022
201709 -0.010 246.819 -0.011
201712 -0.001 246.524 -0.001
201803 -0.002 249.554 -0.002
201806 -0.010 251.989 -0.011
201809 0.000 252.439 0.000
201812 -0.001 251.233 -0.001
201903 0.001 254.202 0.001
201906 -0.003 256.143 -0.003
201909 -0.007 256.759 -0.007
201912 -0.001 256.974 -0.001
202003 -0.010 258.115 -0.011
202006 -0.003 257.797 -0.003
202009 0.000 260.280 0.000
202012 -0.002 260.474 -0.002
202103 -0.003 264.877 -0.003
202106 0.000 271.696 0.000

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.00 mean?
Lattice Biologics (LBLTF) has a E10 of $0.00 as of Jun. 2021. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Lattice Biologics and its competitors.
Is Lattice Biologics' E10 too high?
Lattice Biologics' current E10 is $0.00.
How does Lattice Biologics' E10 compare to ABT and MDT?
Lattice Biologics' E10 of $0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Lattice Biologics and its competitors. Lattice Biologics's current E10 is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lattice Biologics stock overvalued right now?
Lattice Biologics (LBLTF) has a current E10 of $0.00. The current E10 is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Lattice Biologics (LBLTF), the current E10 is $0.00 as of Jun. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lattice Biologics Business Description

Address 512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714
Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The company's products include ADM dermis, DBM Putty, Bone scaffold, and others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.